ANKRD41 inhibitors are a class of chemical compounds designed to target and inhibit the function of the ANKRD41 protein, which belongs to the ankyrin repeat domain-containing protein family. ANKRD41 contains multiple ankyrin repeat motifs, which are structural domains known for mediating protein-protein interactions. These motifs, characterized by repeating helix-loop-helix structures, provide a stable interface for binding to other proteins, enabling ANKRD41 to participate in various cellular processes such as signal transduction, protein localization, and regulatory activities. ANKRD41 inhibitors work by interfering with these protein-protein interactions, preventing ANKRD41 from forming or maintaining the multiprotein complexes it is involved in, thus disrupting the cellular functions that rely on ANKRD41.
The chemical structures of ANKRD41 inhibitors are diverse, ranging from small molecules to peptides and synthetic analogs. These inhibitors are designed to target specific regions within the ankyrin repeat domains, such as hydrophobic pockets or charged residues that are critical for the binding of ANKRD41 to its interacting partners. Some inhibitors mimic the natural ligands of ANKRD41, competing for the same binding sites and preventing the protein from associating with its functional partners. Other inhibitors act by inducing conformational changes in ANKRD41, destabilizing the ankyrin repeat scaffold and hindering its ability to maintain a functional conformation. By blocking these interactions, ANKRD41 inhibitors serve as essential tools for studying the molecular roles of ANKRD41 in cellular systems and understanding how the structural and functional aspects of ankyrin repeat domains contribute to the regulation of protein interactions and complex formation in various biological pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
This compound might downregulate ANKRD41 by preventing histone deacetylases from removing acetyl groups on histones near the ANKRD41 gene, leading to less transcriptionally active chromatin. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By incorporating into DNA during replication, this chemical could reduce ANKRD41 expression through DNA demethylation at the gene promoter region, which might lead to reduced binding of transcription repressors. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
This molecule may lead to the hypomethylation of the promoter region of the ANKRD41 gene, thereby reducing the recruitment of methyl-binding proteins that repress transcription. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 could downregulate ANKRD41 by competitively binding to the bromodomain of BET proteins, potentially decreasing the recruitment of transcriptional machinery to the ANKRD41 promoter. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D could decrease ANKRD41 expression by intercalating into DNA, specifically inhibiting the transcription initiation and elongation processes of the ANKRD41 gene. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
By specifically binding to mTOR and inhibiting its pathway, rapamycin may decrease the translation of ANKRD41 by reducing the overall rate of protein synthesis. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide may inhibit ANKRD41 expression by obstructing the translocation step in protein synthesis on ribosomes, thereby reducing the translation of ANKRD41 mRNA. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Mitomycin C could reduce ANKRD41 expression by crosslinking DNA strands, leading to disruptions in the DNA template necessary for the gene′s transcription. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin could downregulate ANKRD41 by inhibiting kinase enzymes involved in signaling cascades that govern the transcriptional activity of the ANKRD41 gene. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 could inhibit ANKRD41 by blocking PI3K, thereby reducing the phosphorylation of downstream targets involved in the transcriptional activation of the ANKRD41 gene. | ||||||